These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26515411)

  • 41. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
    J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors affecting the outcome of brain metastases from breast cancer.
    Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
    Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re-irradiation for painful bone metastases: evidence-based approach.
    Chiu N; Chiu L; Popovic M; DeAngelis C; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
    Ann Palliat Med; 2015 Oct; 4(4):214-9. PubMed ID: 26541401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reirradiation with local-field radiotherapy for painful bone metastases.
    Hayashi S; Hoshi H; Iida T
    Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life: results from the Dutch Bone Metastasis Study.
    Meeuse JJ; van der Linden YM; van Tienhoven G; Gans RO; Leer JW; Reyners AK;
    Cancer; 2010 Jun; 116(11):2716-25. PubMed ID: 20225326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.
    Kohno N; Aogi K; Minami H; Nakamura S; Asaga T; Iino Y; Watanabe T; Goessl C; Ohashi Y; Takashima S
    J Clin Oncol; 2005 May; 23(15):3314-21. PubMed ID: 15738536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overall response rates to radiation therapy for patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment.
    Bedard G; Hoskin P; Chow E
    Radiother Oncol; 2014 Jul; 112(1):125-7. PubMed ID: 25023043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of survival time in advanced cancer: a prognostic scale for Chinese patients.
    Lingjun Z; Jing C; Jian L; Wee B; Jijun Z
    J Pain Symptom Manage; 2009 Oct; 38(4):578-86. PubMed ID: 19608378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients.
    Kaizu T; Karasawa K; Tanaka Y; Matuda T; Kurosaki H; Tanaka S; Kumazaki T
    Am J Gastroenterol; 1998 Nov; 93(11):2167-71. PubMed ID: 9820391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Three Survival Scores in a Series of Patients ≥80 Years of Age Irradiated for Bone Metastases.
    Rades D; Delikanli C; Schild SE; Kristiansen C; Tvilsted S; Janssen S
    Anticancer Res; 2023 Feb; 43(2):801-807. PubMed ID: 36697108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative bone single-photon emission computed tomography for prediction of pain relief in metastatic bone disease treated with rhenium-186 etidronate.
    Israel O; Keidar Z; Rubinov R; Iosilevski G; Frenkel A; Kuten A; Betman L; Kolodny GM; Yarnitsky D; Front D
    J Clin Oncol; 2000 Jul; 18(14):2747-54. PubMed ID: 10894875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing health related quality of life in cancer patients with bone metastases.
    Wong E; Chow E; Zhang L; Bedard G; Lam K; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    J Palliat Med; 2013 Aug; 16(8):915-21. PubMed ID: 23819731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714.
    Chow E; James JL; Hartsell W; Scarantino CW; Ivker R; Roach M; Suh JH; Demas W; Konski A; Bruner DW
    World J Oncol; 2011 Aug; 2(4):181-190. PubMed ID: 29147245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria.
    McDonald R; Probyn L; Poon I; Erler D; Brotherston D; Soliman H; Cheung P; Chung H; Chu W; Loblaw A; Thavarajah N; Lang C; Chin L; Chow E; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):879-81. PubMed ID: 26530757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
    Wilkins A; Mossop H; Syndikus I; Khoo V; Bloomfield D; Parker C; Logue J; Scrase C; Patterson H; Birtle A; Staffurth J; Malik Z; Panades M; Eswar C; Graham J; Russell M; Kirkbride P; O'Sullivan JM; Gao A; Cruickshank C; Griffin C; Dearnaley D; Hall E
    Lancet Oncol; 2015 Dec; 16(16):1605-16. PubMed ID: 26522334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical progression-free survival in localized prostate cancer patients treated with definitive external beam radiotherapy.
    Rakhsha A; Kashi AS; Mofid B; Houshyari M
    Electron Physician; 2015 Oct; 7(6):1330-5. PubMed ID: 26516438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.